Australia markets closed

NightHawk Biosciences Inc (1HB.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.1660-0.0030 (-1.78%)
At close: 08:00AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,094
6,995
370.176
0
2,948
Cost of revenue
2,737
2,737
81.295
0
-
Gross profit
4,258
4,258
288.881
0
-
Operating expenses
Research development
22,339
20,120
20,223
16,455
12,939
Selling general and administrative
19,599
26,170
20,131
16,828
14,934
Total operating expenses
43,781
46,290
40,354
31,171
27,873
Operating income or loss
-42,050
-42,032
-40,065
-31,171
-24,925
Interest expense
776.838
776.838
182.509
-
-
Total other income/expenses net
-4,254
18.222
-2,331
-5,191
-2,023
Income before tax
-45,519
-42,334
-41,591
-35,547
-26,381
Income tax expense
-361.911
-571.12
-215.937
-145.974
0
Income from continuing operations
-45,157
-41,762
-41,375
-35,401
-26,381
Net income
-44,847
-45,217
-43,435
-35,071
-26,050
Net income available to common shareholders
-44,847
-45,217
-43,435
-35,071
-26,050
Basic EPS
-2.13
-
-1.70
-1.41
-1.63
Diluted EPS
-2.13
-
-1.70
-1.41
-1.63
Basic average shares
25,920
-
25,606
24,914
15,983
Diluted average shares
25,920
-
25,606
24,914
15,983